↓ Skip to main content

KIF11 inhibition for glioblastoma treatment: reason to hope or a struggle with the brain?

Overview of attention for article published in BMC Cancer, June 2009
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
56 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
KIF11 inhibition for glioblastoma treatment: reason to hope or a struggle with the brain?
Published in
BMC Cancer, June 2009
DOI 10.1186/1471-2407-9-196
Pubmed ID
Authors

Silvia Valensin, Chiara Ghiron, Claudia Lamanna, Andreas Kremer, Marco Rossi, Pietro Ferruzzi, Marco Nievo, Annette Bakker

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
United States 1 2%
Brazil 1 2%
Unknown 53 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 21%
Researcher 11 20%
Student > Master 6 11%
Student > Bachelor 5 9%
Student > Doctoral Student 3 5%
Other 9 16%
Unknown 10 18%
Readers by discipline Count As %
Agricultural and Biological Sciences 11 20%
Medicine and Dentistry 9 16%
Biochemistry, Genetics and Molecular Biology 8 14%
Pharmacology, Toxicology and Pharmaceutical Science 4 7%
Chemistry 4 7%
Other 8 14%
Unknown 12 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 October 2015.
All research outputs
#7,552,525
of 23,039,416 outputs
Outputs from BMC Cancer
#2,097
of 8,368 outputs
Outputs of similar age
#37,907
of 112,172 outputs
Outputs of similar age from BMC Cancer
#21
of 48 outputs
Altmetric has tracked 23,039,416 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,368 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 112,172 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.